Viewing Study NCT03821792

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:24 PM
Ignite Modification Date: 2026-01-20 @ 3:34 PM
Study NCT ID: NCT03821792
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-10
First Post: 2019-01-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Prostate Carcinoma View
None Prostate Adenocarcinoma View
None Prostate Carcinoma Metastatic in the Bone View
None Stage IV Prostate Cancer AJCC v8 View
None Stage IVA Prostate Cancer AJCC v8 View
None Stage IVB Prostate Cancer AJCC v8 View
Keywords: